These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis. Ozakbas S, Cagiran I, Ormeci B, Idiman E. J Neurol Sci; 2004 Mar 15; 218(1-2):3-7. PubMed ID: 14759626 [Abstract] [Full Text] [Related]
3. Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis. Meyer-Moock S, Feng YS, Maeurer M, Dippel FW, Kohlmann T. BMC Neurol; 2014 Mar 25; 14():58. PubMed ID: 24666846 [Abstract] [Full Text] [Related]
5. How similar are commonly combined criteria for EDSS progression in multiple sclerosis? Kragt JJ, Nielsen IM, van der Linden FA, Uitdehaag BM, Polman CH. Mult Scler; 2006 Dec 25; 12(6):782-6. PubMed ID: 17263007 [Abstract] [Full Text] [Related]
6. Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite. Hobart J, Kalkers N, Barkhof F, Uitdehaag B, Polman C, Thompson A. Mult Scler; 2004 Feb 25; 10(1):41-6. PubMed ID: 14760951 [Abstract] [Full Text] [Related]
7. Responsiveness and predictive value of EDSS and MSFC in primary progressive MS. Kragt JJ, Thompson AJ, Montalban X, Tintoré M, Río J, Polman CH, Uitdehaag BM. Neurology; 2008 Mar 25; 70(13 Pt 2):1084-91. PubMed ID: 18184917 [Abstract] [Full Text] [Related]
8. The multiple sclerosis functional composite: a new clinical outcome measure for multiple sderosis trials. Rudick RA, Cutter G, Reingold S. Mult Scler; 2002 Oct 25; 8(5):359-65. PubMed ID: 12356200 [Abstract] [Full Text] [Related]
15. Mitoxantrone: a review of its use in multiple sclerosis. Scott LJ, Figgitt DP. CNS Drugs; 2004 Jan 25; 18(6):379-96. PubMed ID: 15089110 [Abstract] [Full Text] [Related]
16. Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis. Patzold T, Schwengelbeck M, Ossege LM, Malin JP, Sindern E. Acta Neurol Scand; 2002 Mar 25; 105(3):164-8. PubMed ID: 11886358 [Abstract] [Full Text] [Related]
17. Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability. Hoogervorst EL, Zwemmer JN, Jelles B, Polman CH, Uitdehaag BM. Mult Scler; 2004 Oct 25; 10(5):569-74. PubMed ID: 15471375 [Abstract] [Full Text] [Related]
18. MS functional composite: relation to disease phenotype and disability strata. Kalkers NF, de Groot V, Lazeron RH, Killestein J, Adèr HJ, Barkhof F, Lankhorst GJ, Polman CH. Neurology; 2000 Mar 28; 54(6):1233-9. PubMed ID: 10746590 [Abstract] [Full Text] [Related]
19. Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Baier ML, Cutter GR, Rudick RA, Miller D, Cohen JA, Weinstock-Guttman B, Mass M, Balcer LJ. Neurology; 2005 Mar 22; 64(6):992-5. PubMed ID: 15781814 [Abstract] [Full Text] [Related]